References

Whole body irradiation – Radiology or medicine?

10.1259/0007-1285-26-305-234 · 1953 · External reference

Systemic effects of local radiotherapy

10.1016/s1470-2045(09)70082-8 · 2009 · External reference

Hunting for abscopal and bystander effects: clinical exploration of non-targeted effects induced by partial high-single-dose irradiation of the hypoxic tumour segment in oligometastatic patients

10.1080/0284186x.2017.1346385 · 2017 · External reference

Radiotherapy and immunotherapy: a beneficial liaison?

10.1038/nrclinonc.2016.211 · 2017 · External reference

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

10.1093/annonc/mdv297 · 2015 · External reference

Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

10.1056/nejmoa1507643 · 2015 · External reference

Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer

10.1056/nejmoa1504627 · 2015 · External reference

Pembrolizumab for the treatment of non-small-cell lung cancer

10.1056/nejmoa1501824 · 2015 · External reference

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

10.1016/s1470-2045(16)30098-5 · 2016 · External reference

Nivolumab versus everolimus in advanced renal-cell carcinoma

10.1056/nejmoa1510665 · 2015 · External reference

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

10.1056/nejmoa1411087 · 2015 · External reference

Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma

10.1200/jco.2014.56.2736 · 2015 · External reference

Ipilimumab safety profile: summary of findings from completed trials in advanced melanoma

2011 · External reference

Radiotherapy and immune checkpoint blockades: a snapshot in 2016

10.3857/roj.2016.02033 · 2016 · External reference

Impact of radiotherapy in patients with advanced melanoma who progressed after ipilimumab 3 mg/kg

10.4161/onci.28780 · 2014 · External reference

A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab

10.1080/2162402x.2015.1046028 · 2015 · External reference

Local tumor treatment in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma. cancer

2016 · External reference

Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review

10.1186/s40425-015-0095-8 · 2015 · External reference

Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone

10.1080/15384047.2016.1264543 · 2017 · External reference

Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma

10.1158/2326-6066.cir-13-0082 · 2013 · External reference

Ipilimumab and whole brain radiation therapy for melanoma brain metastases

10.1007/s11060-014-1617-9 · 2015 · External reference

Radiotherapy to control limited melanoma progression following ipilimumab

10.1097/cji.0000000000000142 · 2016 · External reference

Safety and efficacy of radiation in advanced melanoma patients treated with ipilimumab

10.1016/j.ijrobp.2016.04.017 · 2016 · External reference

Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival

10.3171/2012.5.jns111929 · 2012 · External reference

Ipilimumab and radiation therapy for melanoma brain metastases

10.1002/cam4.140 · 2013 · External reference

Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery

10.1097/cmr.0b013e32835f3d90 · 2013 · External reference

10.1200/jco.2014.32.15_suppl.9076

10.1200/jco.2014.32.15_suppl.9076 · External reference

Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment

10.1016/j.ijrobp.2015.01.004 · 2015 · External reference

Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery

10.1002/cam4.315 · 2015 · External reference

Ipilimumab and stereotactic radiosurgery versus stereotactic radiosurgery alone for newly diagnosed melanoma brain metastases

2015 · External reference

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

10.1093/annonc/mdx225 · 2017 · External reference

Radio-immunotherapy induced immunogenic cancer cells as basis for induction of systemic anti-tumor immune responses – preclinical evidence and ongoing clinical applications

10.3389/fimmu.2015.00505 · 2015 · External reference

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

10.1038/ncomms15618 · 2017 · External reference

10.3389/fonc.2014.00325

10.3389/fonc.2014.00325 · External reference